| 1 |
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology
|
17 Sep 2014 |
2,505 |
| 2 |
Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges
Bruno Dubois, Alessandro Padovani, Philip Scheltens et al. · Journal of Alzheimer s Disease
Open access |
17 Oct 2015 |
586 |
| 3 |
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
Joint IOF-ECTS GIO Guidelines Working Group et al. · Osteoporosis International
|
20 Mar 2012 |
337 |
| 4 |
Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial
Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena et al. · European Urology
|
2 Jan 2007 |
332 |
| 5 |
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum
Vito Lorusso, C. F. Pollera, Mauro Antimi et al. · European Journal of Cancer
|
Jul 1998 |
289 |
| 6 |
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
Charles S. Fuchs et al. · The Lancet Oncology
Open access144 authors |
Feb 2019 |
288 |
| 7 |
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus
Gérard Reach, Valeria Pechtner, Raffaella Gentilella et al. · Diabetes & Metabolism
Open access |
25 Jul 2017 |
255 |
| 8 |
Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma
Jacek Jassem, Rodryg Ramlau, Armando Santoro et al. · Journal of Clinical Oncology
Open access |
29 Mar 2008 |
230 |
| 9 |
Treatment failure in osteoporosis
for the IOF CSA Inadequate Responders Working Group, Adolfo Díez‐Pérez, Jonathan Derrick Adachi et al. · Osteoporosis International
|
26 Jul 2012 |
228 |
| 10 |
Glucagon‐like peptide‐1 receptor agonists in type 2 diabetes treatment: are they all the same?
Raffaella Gentilella, Valeria Pechtner, Antonella Corcos et al. · Diabetes/Metabolism Research and Reviews
|
30 Aug 2018 |
224 |
| 11 |
D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties
Marco Scarselli, Francesca Novi, Ester Schallmach et al. · Journal of Biological Chemistry
Open access |
Aug 2001 |
217 |
| 12 |
Prevalence of virulence factors in enterotoxigenic Escherichia coli isolated from pigs with post-weaning diarrhoea in Europe
Andrea Luppi, Mariavittoria Gibellini, Thomas J. Gin et al. · Porcine Health Management
Open access |
21 Jul 2016 |
188 |
| 13 |
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention
Vladimir Skljarevski, Tina Marie Myers Oakes, Qi Zhang et al. · JAMA Neurology
Open access |
18 Dec 2017 |
176 |
| 14 |
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro
Anna Taranta, Marina Brama, Anna Maria Teti et al. · Bone
|
Feb 2002 |
167 |
| 15 |
Growth hormone (GH) treatment to final height in children with idiopathic short stature: Evidence for a dose effect
Jan Maarten Wit, Lyset T. M. Rekers-Mombarg, Gordon B. Cutler et al. · The Journal of Pediatrics
|
2005 |
155 |
| 16 |
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Angelo Camporeale, David Kudrow, Ryan Sides et al. · BMC Neurology
Open access |
9 Nov 2018 |
142 |
| 17 |
Fluoxetine: a review on evidence based medicine
Andrea Rossi, Alessandra Barraco, Pietro Donda · Annals of General Hospital Psychiatry
Open access |
12 Feb 2004 |
133 |
| 18 |
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine
Raffaella Molteni, Francesca Calabrese, Annamaria Cattaneo et al. · Neuropsychopharmacology
|
19 Nov 2008 |
130 |
| 19 |
Fracture Incidence and Characterization in Patients on Osteoporosis Treatment: The ICARO Study
Silvano Adami, Giancarlo Isaia, G. Luisetto et al. · Journal of Bone and Mineral Research
Open access |
22 Sep 2006 |
126 |
| 20 |
Human Growth Hormone Replacement in Adult Hypopituitary Patients: Long-Term Effects on Body Composition and Lipid Status—3-Year Results from the HypoCCS Database
Andrea F. Attanasio, PETER C. BATES, Ken K. Y. Ho et al. · The Journal of Clinical Endocrinology & Metabolism
|
Apr 2002 |
123 |
| 21 |
Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk
Jean‐Yves Reginster, Somnath Sarkar, Brigitte Zegels et al. · Bone
|
2 Dec 2003 |
116 |
| 22 |
Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours
Josep María Haro, Kristin Kahle‐Wrobleski, Giuseppe Bruno et al. · The journal of nutrition health & aging
Open access |
Aug 2014 |
113 |
| 23 |
Exenatide: a review from pharmacology to clinical practice
Raffaella Gentilella, Cristina Bianchi, Andrea da Silveira Rossi et al. · Diabetes Obesity and Metabolism
|
6 Apr 2009 |
111 |
| 24 |
Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch
Paolo Paoletti, E. Fornai, Fabrizio Maggiorelli et al. · European Respiratory Journal
Open access |
Apr 1996 |
110 |
| 25 |
Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment
Francesca Calabrese, Gianluigi Guidotti, Raffaella Molteni et al. · PLoS ONE
Open access |
29 May 2012 |
110 |
| 26 |
Recombinant Human GH Replacement Therapy and Thyroid Function in a Large Group of Adult GH-Deficient Patients: When Does l -T4Therapy Become Mandatory?
Silvia Porretti, Claudia Giavoli, Cristina Lucia Ronchi et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
May 2002 |
108 |
| 27 |
Predictive Value of Circulating Insulin-Like Growth Factor I Levels in Ischemic Stroke Outcome
Marta Bondanelli, Maria Rosaria Ambrosio, Alessandro Onofri et al. · The Journal of Clinical Endocrinology & Metabolism
|
2 Aug 2006 |
107 |
| 28 |
Anterior Pituitary Function May Predict Functional and Cognitive Outcome in Patients with Traumatic Brain Injury Undergoing Rehabilitation
Marta Bondanelli, Maria Rosaria Ambrosio, Lorenza Cavazzini et al. · Journal of Neurotrauma
|
Nov 2007 |
104 |
| 29 |
Continued Growth Hormone (GH) Treatment after Final Height Is Necessary to Complete Somatic Development in Childhood-Onset GH-Deficient Patients
Andrea F. Attanasio, Elena P. Shavrikova, Werner Friedrich Blum et al. · The Journal of Clinical Endocrinology & Metabolism
|
Oct 2004 |
100 |
| 30 |
Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient
Giovanni Corona, Nicola Mondaini, Andrea Ungar et al. · The Journal of Sexual Medicine
|
13 Oct 2011 |
98 |
| 31 |
Growth Hormone Secretion and Leptin in Morbid Obesity before and after Biliopancreatic Diversion: Relationships with Insulin and Body Composition
Laura De Marinis, Antonio Bianchi, A. Mancini et al. · The Journal of Clinical Endocrinology & Metabolism
|
2004 |
96 |
| 32 |
Body Composition, IGF-I and IGFBP-3 Concentrations as Outcome Measures in Severely GH-Deficient (GHD) Patients after Childhood GH Treatment: A Comparison with Adult Onset GHD Patients
Andrea F. Attanasio, Simon James Howell, PETER C. BATES et al. · The Journal of Clinical Endocrinology & Metabolism
|
Jul 2002 |
89 |
| 33 |
The role of patient preferences in adherence to treatment in chronic disease: a narrative review
Serena Losi, Cesare Berra, Riccardo Fornengo et al. · Drug Target Insights
ReviewOpen access |
8 Nov 2021 |
88 |
| 34 |
Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods
Paolo Girardi, Maurizio Pompili, Marco Innamorati et al. · Human Psychopharmacology Clinical and Experimental
|
19 Feb 2009 |
86 |
| 35 |
A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer
Giuseppe Roberto D’Agostino, Josep-Maria Del Campo, Begoña Mellado et al. · International Journal of Gynecological Cancer
|
2006 |
82 |
| 36 |
Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study
Gianni Pezzoli, Emilia Martignoni, Claudio Pacchetti et al. · Movement Disorders
|
1994 |
80 |
| 37 |
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
Li‐Tzong Chen, Do‐Youn Oh, Min‐Hee Ryu et al. · Cancer Research and Treatment
ReviewOpen access |
4 Jan 2017 |
77 |
| 38 |
The first spectroscopic analysis of Ethiopian prehistoric rock painting
Cristiana Lofrumento, Marilena Ricci, Luca Bachechi et al. · Journal of Raman Spectroscopy
Open access |
16 Nov 2011 |
75 |
| 39 |
The use of phosphodiesterase 5 inhibitors with concomitant medications
Giovanni Corona, Elisa Razzoli, Gianni Forti et al. · Journal of Endocrinological Investigation
|
Sep 2008 |
74 |
| 40 |
Leptin Regulates GH Gene Expression and Secretion and Nitric Oxide Production in Pig Pituitary Cells
Mario Baratta, Roberta Saleri, Gian Luca Mainardi et al. · Endocrinology
|
Feb 2002 |
72 |
| 41 |
A systematic review of the cost of ketosis in dairy cattle
Juan M. Cainzos, Cristina Andreu‐Vázquez, Marcello Guadagnini et al. · Journal of Dairy Science
ReviewOpen access |
7 May 2022 |
71 |
| 42 |
An Evaluation of an Alternative Dosing Regimen with Tadalafil, 3 Times/Week, for Men with Erectile Dysfunction: SURE Study in 14 European Countries
Vincenzo G. Mirone, Pierre Costa, Jan‐Erik Damber et al. · European Urology
|
11 Mar 2005 |
71 |
| 43 |
Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency
Peter Herschbach, Gerhard Henrich, CJ Strasburger et al. · European Journal of Endocrinology
|
Sep 2001 |
69 |
| 44 |
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
Juan W. Valle et al. · The Lancet Oncology
|
27 Sep 2021 |
68 |
| 45 |
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement
Francesco Giorgino, Alfred Penfornis, Valeria Pechtner et al. · Patient Preference and Adherence
Open access |
May 2018 |
68 |
| 46 |
H2 antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients
Emilio Sacchetti, Laura Guarneri, Daniele Bravi · Biological Psychiatry
|
Jul 2000 |
66 |
| 47 |
BDNF Level in the Rat Prefrontal Cortex Increases Following Chronic but Not Acute Treatment with Duloxetine, a Dual Acting Inhibitor of Noradrenaline and Serotonin Re-uptake
Claudio Mannari, Nicola Origlia, Alessia Scatena et al. · Cellular and Molecular Neurobiology
Open access |
2 Jan 2008 |
63 |
| 48 |
Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg/m2) and high-dose (875 mg/m2) levels
Camillo F. Pollera, Anna Ceribelli, Marcello Crecco et al. · Investigational New Drugs
|
Jun 1997 |
62 |
| 49 |
Feed supplemented with 3 different antibiotics improved food intake and decreased the activation of the humoral immune response in healthy weaned pigs but had differing effects on intestinal microbiota1
Paolo Bosi, Giuseppe Merialdi, S. Scandurra et al. · Journal of Animal Science
|
4 Jul 2011 |
61 |
| 50 |
Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study
Carsten Henneges, Catherine C. Reed, Yunfei Chen et al. · Journal of Alzheimer s Disease
Open access |
23 May 2016 |
60 |